549 related articles for article (PubMed ID: 9863388)
1. [Aplastic anemia--clinical characteristics and survival analysis].
Milosević R; Antonijević N; Janković G; Babić D; Colović M
Srp Arh Celok Lek; 1998; 126(7-8):234-8. PubMed ID: 9863388
[TBL] [Abstract][Full Text] [Related]
2. [Histopathologic characteristics of bone marrow in patients with aplastic anemia].
Milosević R; Janković G; Antonijević N; Jovanović V; Babić D; Colović M
Srp Arh Celok Lek; 2000; 128(5-6):200-4. PubMed ID: 11089422
[TBL] [Abstract][Full Text] [Related]
3. [Survival in amyotrophic lateral sclerosis].
Alcaz S; Jarebinski M; Pekmezović T; Marinković Z; Apostolski S
Srp Arh Celok Lek; 1997; 125(1-2):19-23. PubMed ID: 17974351
[TBL] [Abstract][Full Text] [Related]
4. Malignant tumors occurring after treatment of aplastic anemia. European Bone Marrow Transplantation-Severe Aplastic Anaemia Working Party.
Socié G; Henry-Amar M; Bacigalupo A; Hows J; Tichelli A; Ljungman P; McCann SR; Frickhofen N; Van't Veer-Korthof E; Gluckman E
N Engl J Med; 1993 Oct; 329(16):1152-7. PubMed ID: 8377778
[TBL] [Abstract][Full Text] [Related]
5. Treatment of aplastic anemia with antilymphocyte globulin and methylprednisolone with or without cyclosporine. The German Aplastic Anemia Study Group.
Frickhofen N; Kaltwasser JP; Schrezenmeier H; Raghavachar A; Vogt HG; Herrmann F; Freund M; Meusers P; Salama A; Heimpel H
N Engl J Med; 1991 May; 324(19):1297-304. PubMed ID: 2017225
[TBL] [Abstract][Full Text] [Related]
6. Acquired severe aplastic anaemia in adults--a single centre study with 13 years follow-up.
de Planque MM; Richel DJ; Fibbe WE; den Ottolander GJ; Guiot HF; Zwaan FE
Neth J Med; 1990 Oct; 37(3-4):103-10. PubMed ID: 2250751
[TBL] [Abstract][Full Text] [Related]
7. Treatment of severe aplastic anemia with high-dose methylprednisolone and antilymphocyte globulin.
Marmont AM; Bacigalupo A; Van Lint MT; Frassoni F; Podesta M; Reali G; Piaggio G
Prog Clin Biol Res; 1984; 148():271-87. PubMed ID: 6379665
[TBL] [Abstract][Full Text] [Related]
8. Hematopoietic stem cell transplantation for high-risk adult patients with severe aplastic anemia; reduction of graft failure by enhancing stem cell dose.
Min CK; Kim DW; Lee JW; Han CW; Min WS; Kim CC
Haematologica; 2001 Mar; 86(3):303-10. PubMed ID: 11255278
[TBL] [Abstract][Full Text] [Related]
9. Aetiology of severe aplastic anaemia and outcome after allogeneic bone marrow transplantation or immunosuppression therapy. Working Party on Severe Aplastic Anaemia of the European Blood and Marrow Transplantation Group.
Bacigalupo A
Eur J Haematol Suppl; 1996; 60():16-9. PubMed ID: 8987236
[TBL] [Abstract][Full Text] [Related]
10. Quality-adjusted survival analysis shows differences in outcome after immunosuppression or bone marrow transplantation in aplastic anemia.
Viollier R; Passweg J; Gregor M; Favre G; Kühne T; Nissen C; Gratwohl A; Tichelli A
Ann Hematol; 2005 Jan; 84(1):47-55. PubMed ID: 15340760
[TBL] [Abstract][Full Text] [Related]
11. [Twenty years of severe aplastic anemia treatment at Department of Hematology, University Department of Medicine, Zagreb University Hospital Center, Zagreb, Croatia].
Mrsić M; Seiwerth RS; Labar B; Bogdanić V; Nemet D; Duraković N; Mikulić M; Sertić D; Aurer I; Radman I; Zupancić-Salek S
Acta Med Croatica; 2009 Jun; 63(3):209-14. PubMed ID: 19827347
[TBL] [Abstract][Full Text] [Related]
12. Improved survival in severe acquired aplastic anemia of childhood.
Fouladi M; Herman R; Rolland-Grinton M; Jones-Wallace D; Blanchette V; Calderwood S; Doyle J; Halperin D; Leaker M; Saunders EF; Zipursky A; Freedman MH
Bone Marrow Transplant; 2000 Dec; 26(11):1149-56. PubMed ID: 11149724
[TBL] [Abstract][Full Text] [Related]
13. Successful allogeneic hematopoietic stem cell transplantation using triple agent immunosuppression in severe aplastic anemia patients.
Kim HJ; Park CY; Park YH; Kim YJ; Kim DW; Min WS; Kim CC
Bone Marrow Transplant; 2003 Jan; 31(2):79-86. PubMed ID: 12621487
[TBL] [Abstract][Full Text] [Related]
14. [Favorable current prognosis after HLA-identical bone marrow transplantation for children with required severe aplastic anemia; evaluation of 30 years of bone marrow transplantation at the Leiden University Medical Center].
van Steekelenburg M; van Weel-Sipman MH; Zwinderman AH; Hoogerbrugge PM; Vossen JM; Egeler RM
Ned Tijdschr Geneeskd; 2002 Aug; 146(33):1542-6. PubMed ID: 12212502
[TBL] [Abstract][Full Text] [Related]
15. Immunosuppressive therapy versus bone marrow transplantation for children with aplastic anemia.
Werner EJ; Stout RD; Valdez LP; Harris RE
Pediatrics; 1989 Jan; 83(1):61-5. PubMed ID: 2642621
[TBL] [Abstract][Full Text] [Related]
16. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
17. Severe acquired aplastic anemia in children: 11-year experience with bone marrow transplantation and immunosuppressive therapy.
Halpérin DS; Grisaru D; Freedman MH; Saunders EF
Am J Pediatr Hematol Oncol; 1989; 11(3):304-9. PubMed ID: 2675660
[TBL] [Abstract][Full Text] [Related]
18. CsA-based post-graft immunosuppression: the main factor for improving outcome of allografted patients with acquired aplastic anemia. A retrospective survey by the Spanish Group of Hematopoietic Transplantation.
Arranz R; Conde E; Rodriguez-Salvanés F; Pajuelo FJ; Cabrera R; Sanz MA; Petit J; Bueno J; Maldonado J; Odriozola J; Conde JG; Brunet S; Carreras E; Iriondo A; Fernández-Rañada JM; Marín P;
Bone Marrow Transplant; 2002 Feb; 29(3):205-11. PubMed ID: 11859392
[TBL] [Abstract][Full Text] [Related]
19. Aplastic anaemia in Christchurch Hospital 1979-89.
Baker BW; Smith MP; Abbott GD; Beard ME; Spearing RL; Heaton DC
N Z Med J; 1991 Nov; 104(923):468-70. PubMed ID: 1945172
[TBL] [Abstract][Full Text] [Related]
20. [Hematopoietic stem-cell transplantation in aplastic anemia].
Hernández-Rivera EG
Rev Invest Clin; 2005; 57(2):298-304. PubMed ID: 16524071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]